 - Concurrent use of any testosterone, androgen, anabolic steroids, DHEAdehydroepiandrosterone or hormonal products for at least 2 weeks prior to screening and during the study. Oral contraceptive use for control of endometriosis symptoms is acceptable for the first 28-days of the study. 